LYTIR

Company · ABEO

Abeona Therapeutics Inc.

Name as listed on its exchange; filed with the SEC as ABEONA THERAPEUTICS INC.

Nasdaq's symbol directory lists ABEO on Nasdaq as “Abeona Therapeutics Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 1 occasion ($34K); insiders sold on 12 occasions ($1.3M); 4 planned-sale notices; 5 filings by holders of 5% or more; 3 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $34K in total; Insider sales: $1.3M in total.Jun: Insider sales $169KJul: Insider sales $828KSep: Insider sales $296KNov: Insider purchases $34KDecJanFebMarAprMayJunJulAugSepOctNov$34K$828K
Insider purchases above the line: $34KInsider sales below: $1.3M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Seshadri Vishwas, Chief Executive Officer sold on 2 days latest Sep 29, 2026 sold $574K
  2. Vazzano Joseph Walter, Chief Financial Officer sold on 3 days latest Sep 29, 2026 sold $230K
  3. O'Malley Brendan M., SVP, Chief Legal Officer sold on 2 days latest Sep 29, 2026 sold $119K
  4. Vasanthavada Madhav, Chief Commercial Officer sold on 2 days latest Sep 29, 2026 sold $113K
  5. Silverstein Christine Berni sold on 1 day latest Jun 15, 2026 sold $104K
  6. Alvino Mark sold on 1 day latest Sep 1, 2026 sold $88K
  7. Alland Leila sold on 1 day latest Jun 30, 2026 sold $65K
  8. Faith L. Charles bought on 1 day latest Nov 13, 2026 bought $34K
Every trade (13)
  1. BUYFaith L. Charles bought Nov 13, 2026 15,000 shares filing $34K
  2. SELLSeshadri Vishwas, Chief Executive Officer sold Sep 29, 2026 19,608 shares filing $101K
  3. SELLVazzano Joseph Walter, Chief Financial Officer sold Sep 29, 2026 9,191 shares filing $47K
  4. SELLO'Malley Brendan M., SVP, Chief Legal Officer sold Sep 29, 2026 6,727 shares filing $35K
  5. SELLVasanthavada Madhav, Chief Commercial Officer sold Sep 29, 2026 4,902 shares filing $25K
  6. SELLAlvino Mark sold Sep 1, 2026 15,000 shares filing $88K
  7. SELLVazzano Joseph Walter, Chief Financial Officer sold Jul 21, 2026 1,478 shares filing $10K
  8. SELLSeshadri Vishwas, Chief Executive Officer sold Jul 9, 2026 67,971 shares filing $473K
  9. SELLVazzano Joseph Walter, Chief Financial Officer sold Jul 9, 2026 24,880 shares filing $173K
  10. SELLVasanthavada Madhav, Chief Commercial Officer sold Jul 9, 2026 12,606 shares filing $88K
  11. SELLO'Malley Brendan M., SVP, Chief Legal Officer sold Jul 9, 2026 12,050 shares filing $84K
  12. SELLAlland Leila sold Jun 30, 2026 11,000 shares filing $65K
  13. SELLSilverstein Christine Berni sold Jun 15, 2026 18,160 shares filing $104K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Seshadri Vishwas filed Sep 29, 2026 Officer 19,608 shares planned sale date 09/29/2026 filing $101K
  2. Vazzano Joseph Walter filed Sep 29, 2026 Officer 9,191 shares planned sale date 09/29/2026 filing $47K
  3. O'Malley Brendan M. filed Sep 29, 2026 Officer 6,727 shares planned sale date 09/29/2026 filing $35K
  4. Vasanthavada Madhav filed Sep 29, 2026 Officer 4,902 shares planned sale date 09/29/2026 filing $25K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. TPG GP A, LLC filed Nov 16, 2026 Schedule 13G passive filing 7%
  2. Funicular Funds, LP filed Nov 13, 2026 Schedule 13G/A passive filing 7.5%
  3. Daniel Kaufman filed Nov 12, 2026 Schedule 13G/A passive 4,159,099 shares filing 7.3%
  4. James Russell Revocable Trust filed Oct 23, 2026 Schedule 13D may seek influence 3,479,963 shares filing 6.1%
  5. Montanova Capital, LLC filed Aug 14, 2026 Schedule 13G/A passive filing 0.9%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition; Regulation FD disclosure filing Nov 9, 2026
  2. Entry into a material definitive agreement; Completion of acquisition or disposition of assets; Unregistered sales of equity securities; Regulation FD disclosure filing Nov 9, 2026
  3. Regulation FD disclosure filing Sep 15, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.